Additional studies, using whole exome or genome sequencing, to reveal the exact role of underlying gene variants in disease expression, gene-to-gene interactions that result in overlap syndromes, the type of inheritance explaining variability in penetrance and expressivity of disease, and, finally, to better describe the expanding phenotypic spectrum of NOD2-associated disease, are warranted. This evidence concerns the gene NOD2 and connective tissue disorder.